Indaptus Therapeutics Inc Asset Resilience Ratio

Latest as of June 2026: 33.37%

Indaptus Therapeutics Inc asset resilience ratio. Indaptus Therapeutics Inc (INDP) has an Asset Resilience Ratio of 33.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INDP days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$4.00 Million

Cash + Short-term Investments

Total Assets

$11.99 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Indaptus Therapeutics Inc (2010–2023)

Asset resilience ratio of Indaptus Therapeutics Inc from 2010 to 2023. This chart shows how Indaptus Therapeutics Inc's Asset Resilience Ratio has changed over time. Read Indaptus Therapeutics Inc (INDP) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Indaptus Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see INDP total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$4.00 Million	33.37%
Total Liquid Assets	$4.00 Million	33.37%

Asset Resilience Insights

Very High Liquidity: Indaptus Therapeutics Inc maintains exceptional liquid asset reserves at 33.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Indaptus Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Indaptus Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Indaptus Therapeutics Inc Asset Resilience Ratio by Year (2010–2023)

Indaptus Therapeutics Inc asset resilience ratio by year from 2010 to 2023. The table below shows the annual Asset Resilience Ratio data for Indaptus Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	$0.00	$14.92 Million	--
2022-12-31	59.88%	$16.81 Million	$28.06 Million	--
2021-12-31	0.00%	$0.00	$40.58 Million	--
2019-12-31	3.62%	$770.00K	$21.28 Million	+1.45pp
2018-12-31	2.17%	$1.33 Million	$61.51 Million	-0.66pp
2017-12-31	2.83%	$1.82 Million	$64.55 Million	-4.66pp
2016-12-31	7.49%	$1.85 Million	$24.72 Million	-11.40pp
2015-12-31	18.90%	$7.04 Million	$37.28 Million	+2.81pp
2014-12-31	16.08%	$2.01 Million	$12.49 Million	-21.59pp
2013-12-31	37.67%	$5.15 Million	$13.68 Million	-1.86pp
2012-12-31	39.53%	$3.07 Million	$7.77 Million	+22.72pp
2011-12-31	16.81%	$1.52 Million	$9.06 Million	-23.81pp
2010-12-31	40.62%	$5.09 Million	$12.54 Million	--

pp = percentage points

About Indaptus Therapeutics Inc

NASDAQ:INDP USA Biotechnology

Market Cap

$431.71 Million

Market Cap Rank

#14271 Global

#3426 in USA

Share Price

$3.24

Change (1 day)

-7.43%

52-Week Range

$0.94 - $4.75

All Time High

$8680.00